Moderate Revenue, Sector Growth Expected; M&A Slows

NEW YORK, June 22 –Pharmaceutical executives say they will focus as much time and energy ahead in navigating the regulatory environment as they will on organic growth,  according to a recent survey by KPMG LLP, the U.S. audit, tax and advisory firm.

NSF International, a global independent public health organization with 66 years of experience, including 25 years of pharmaceutical expertise through its NSF Health Sciences Division, is launching NSF Reference Standards™, which will produce reference standards that are traceable to official U.S. and European pharmacopeial standards.